Thomas L Ekstrom

8PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 18, 2026
KLF5 controls subtype-independent highly interactive enhancers in pancreatic cancer to regulate cell survival.

Thomas L Ekstrom, Zhangshuai Dai, Julia Thiel

|Nov 13, 2025
Transcriptional pause release at enhancers mediates cell identity.

Thomas L Ekstrom, Steven A Johnsen

|May 22, 2024
USP44 Overexpression Drives a MYC-Like Gene Expression Program in Neuroblastoma through Epigenetic Reprogramming.

Thomas L Ekstrom, Sajjad Hussain, Tibor Bedekovics

|Nov 23, 2021
Repurposing Ceritinib Induces DNA Damage and Enhances PARP Inhibitor Responses in High-Grade Serous Ovarian Carcinoma.

Arun Kanakkanthara, Xiaonan Hou, Thomas L Ekstrom

|Jul 05, 2021
VLX600 Disrupts Homologous Recombination and Synergizes with PARP Inhibitors and Cisplatin by Inhibiting Histone Lysine Demethylases.

Thomas L Ekstrom, Nicholas M Pathoulas, Amelia M Huehls

Pageof 2